{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n    ", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "S. 752"}, "official-title": {"#tail": "\n  ", "#text": "To require the Secretary of Health and Human Services to\n\t\t  promulgate regulations regarding the authorship, content, format, and\n\t\t  dissemination of Patient Medication Information to ensure patients receive\n\t\t  consistent and high-quality information about their prescription medications\n\t\t  and are aware of the potential risks and benefits of prescription\n\t\t  medications."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20130417", "#text": "April 17, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "sponsor": {"#tail": "introduced the following bill; which was read twice and referred to the", "#text": "Mrs. Gillibrand", "@name-id": "S331"}, "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor,\n\t\t\t and Pensions"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Cody Miller Initiative for Safer\n\t\t\t Prescriptions Act"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "the following:", "@entity-type": "act", "#text": "section 505E", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "is amended by inserting after", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "(", "@entity-type": "act", "#text": "Chapter V of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Patient\n\t\t\t medication information for prescription drugs"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "505F."}, "header": {"#tail": "\n          ", "#text": "Patient\n\t\t\t\tmedication information for prescription drugs"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "shall issue regulations regarding the authorship,\n\t\t\t\tcontent, format, and dissemination requirements for patient medication\n\t\t\t\tinformation (referred to in this section as", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}], "term": {"#tail": ") for drugs subject\n\t\t\t\tto", "#text": "PMI"}, "#text": "Not later than 2 years after the date of enactment of\n\t\t\t\tthis section, the"}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n            ", "@id": "id7e439920f90b40c593de3da38d6c73d6"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "shall require that the PMI with\n\t\t\t\trespect to a drug\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505F/ss:a", "@proposed": "true"}, "#text": "The\n\t\t\t\tregulations promulgated under"}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Content"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "and\n\t\t\t\tauthoritative, peer-reviewed literature; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, "#text": "be scientifically\n\t\t\t\taccurate and based on the professional labeling approved by the"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "ida7c52660a06c4e04ad104c545fa869d9", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n              ", "#text": "includes\n\t\t\t\tnontechnical, understandable, plain language that is not promotional in tone or\n\t\t\t\tcontent, and contains at least\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "id913e8bde9004406ba6a7e38b95a5ca6b", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") and as a drug that is the subject of an\n\t\t\t\tapproved abbreviated new drug application under", "@entity-type": "act", "#text": "section 505(j)(2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A"}, {"#tail": "or of an\n\t\t\t\tapproved license for a biological product submitted under", "@entity-type": "act", "#text": "section 505(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ", if applicable;", "@entity-type": "act", "#text": "section 351(k) of the\n\t\t\t\tPublic Health Service Act", "@value": "Public Health Service Act/s:351/ss:k"}], "#text": "the established\n\t\t\t\tname of drug, including the established name of such drug as a listed drug (as\n\t\t\t\tdescribed in"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id13c29c29e94f46f6a18c6c4d4cf5dc24", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "drug uses and\n\t\t\t\tclinical benefits;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id870e0c61844b4ce2ad327278fbbb16ca", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "general\n\t\t\t\tdirections for proper use;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "ida719636afcc84896a07104c9745cf7c0", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "contraindications,\n\t\t\t\tcommon side effects, and most serious risks of the drug, especially with\n\t\t\t\trespect to certain groups such as children, pregnant women, and the\n\t\t\t\telderly;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id0ea55ebffcd9422d88f67b5bbb797a1e", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "measures patients\n\t\t\t\tmay be able to take, if any, to reduce the side effects and risks of the\n\t\t\t\tdrug;"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id763b843781db4c75b9c1c7bf83c71dca", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "when a patient\n\t\t\t\tshould contact his or her health care professional;"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "id14ea989028f142f993a98c7449bb7c66", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "instructions not\n\t\t\t\tto share medications, and, if any exist, key storage requirements, and\n\t\t\t\trecommendations relating to proper disposal of any unused portion of the drug;\n\t\t\t\tand"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "id0cb57c33017b495185c9aa3d7425ac1e", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "known clinically\n\t\t\t\timportant interactions with other drugs and substances."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "idaad819a411754306a157ffbc219547a2", "#text": "\n                "}]}], "#text": "\n            ", "@id": "id256a68871ee4467bbfc257d7f8c40b7f"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "shall include standards related to\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505F/ss:a", "@proposed": "true"}, "#text": "The regulations promulgated under"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Timeliness,\n\t\t\t\tconsistency, and accuracy"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "performing timely\n\t\t\t\tupdates of drug information as new drugs and new information becomes\n\t\t\t\tavailable;"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "ida54e7c20ddea4c238c4c8d3eaa5b36c4", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "ensuring that\n\t\t\t\tcommon information is applied consistently and simultaneously across similar\n\t\t\t\tdrug products and for drugs within classes of medications in order to avoid\n\t\t\t\tpatient confusion and harm; and"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "idfd09a5b112c14fa6aa908051e1efe9fc", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "developing a\n\t\t\t\tprocess, including consumer testing, to assess the quality and effectiveness of\n\t\t\t\tPMI in ensuring that PMI promotes patient understanding and safe and effective\n\t\t\t\tmedication use."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "idb865f79f8f2e43aabac0eeddae80de0a", "#text": "\n              "}], "#text": "\n            ", "@id": "id49a3687d19ab4e7ba4a19002e5c5bfa5"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "shall\n\t\t\t\tprovide for the development of a publicly accessible electronic repository for\n\t\t\t\tall PMI documents and content to facilitate the availability of\n\t\t\t\tPMI.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505F/ss:a", "@proposed": "true"}, "#text": "The regulations promulgated under"}, "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Electronic\n\t\t\t\trepository"}, "#text": "\n            ", "@id": "idb6f0e5db64ca4858a6871ef2be01863a"}], "#text": "\n          ", "@id": "IDb1fbe0398ab84aa29a82a09e5082a74f"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id31426cebabac48888f10f11d4f8a1e09"}, "#text": "\n      ", "@id": "idAA61AF00658E4330A743C9B4335C8370"}, {"#tail": "\n  ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "shall publish on the Internet website of the", "@entity-type": "federal-body", "#text": "Secretary\n\t\t\t of Health and Human Services", "@entity-id": "7500"}, {"#tail": "a link to the Daily Med website\n\t\t\t (http://dailymed.nlm.nih.gov/dailymed) (or any successor website).", "@entity-type": "federal-body", "#text": "Food\n\t\t\t and Drug Administration", "@entity-id": "7524"}], "#text": "The", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Publication on\n\t\t\t internet website"}, "#text": "\n      ", "@id": "id1285d1bb0fb94349874b2ae38571fdf9"}], "#text": "\n    "}, "metadata": {"#tail": "\n  ", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n      ", "#text": "2013-04-17"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n      ", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n      ", "#text": "EN"}, "#tail": "\n  ", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n      ", "#text": "113 S752 IS: Cody Miller Initiative for Safer Prescriptions Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n    ", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n      ", "#text": "U.S. Senate"}, "#text": "\n      "}, "#text": "\n    "}}}